335 related articles for article (PubMed ID: 21764184)
21. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM
Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
Dobrikov GM; Valcheva V; Stoilova-Disheva M; Momekov G; Tzvetkova P; Chimov A; Dimitrov V
Eur J Med Chem; 2012 Feb; 48():45-56. PubMed ID: 22154833
[TBL] [Abstract][Full Text] [Related]
23. New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.
Ancizu S; Moreno E; Solano B; Villar R; Burguete A; Torres E; Pérez-Silanes S; Aldana I; Monge A
Bioorg Med Chem; 2010 Apr; 18(7):2713-9. PubMed ID: 20233660
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
25. Quinonoid and phenazine compounds: synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis.
Carneiro PF; Pinto Mdo C; Coelho TS; Cavalcanti BC; Pessoa C; de Simone CA; Nunes IK; de Oliveira NM; de Almeida RG; Pinto AV; de Moura KC; da Silva PA; da Silva Júnior EN
Eur J Med Chem; 2011 Sep; 46(9):4521-9. PubMed ID: 21820768
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
Jaso A; Zarranz B; Aldana I; Monge A
J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
28. Microwave assisted one-pot synthesis of highly potent novel isoniazid analogues.
Manjashetty TH; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 Apr; 21(7):2125-8. PubMed ID: 21320779
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of antitubercular activity of glycosyl thio- and sulfonyl acetamide derivatives.
Ghosh S; Tiwari P; Pandey S; Misra AK; Chaturvedi V; Gaikwad A; Bhatnagar S; Sinha S
Bioorg Med Chem Lett; 2008 Jul; 18(14):4002-5. PubMed ID: 18579372
[TBL] [Abstract][Full Text] [Related]
30. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints.
Kumar A; Chaturvedi V; Bhatnagar S; Sinha S; Siddiqi MI
J Chem Inf Model; 2009 Jan; 49(1):35-42. PubMed ID: 19063713
[TBL] [Abstract][Full Text] [Related]
31. Novel 2-(2-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives as anti-tubercular agents.
Telvekar VN; Bairwa VK; Satardekar K; Bellubi A
Bioorg Med Chem Lett; 2012 Jan; 22(1):649-52. PubMed ID: 22079026
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
33. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues.
Nagesh HN; Suresh N; Mahalakshmi Naidu K; Arun B; Padma Sridevi J; Sriram D; Yogeeswari P; Chandra Sekhar KV
Eur J Med Chem; 2014 Mar; 74():333-9. PubMed ID: 24486416
[TBL] [Abstract][Full Text] [Related]
35. Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages.
Luo X; Pires D; Aínsa JA; Gracia B; Duarte N; Mulhovo S; Anes E; Ferreira MJ
J Ethnopharmacol; 2013 Mar; 146(1):417-22. PubMed ID: 23337743
[TBL] [Abstract][Full Text] [Related]
36. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.
Ortega MA; Sainz Y; Montoya ME; Jaso A; Zarranz B; Aldana I; Monge A
Arzneimittelforschung; 2002; 52(2):113-9. PubMed ID: 11878199
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.
Ahsan MJ; Samy JG; Soni S; Jain N; Kumar L; Sharma LK; Yadav H; Saini L; Kalyansing RG; Devenda NS; Prasad R; Jain CB
Bioorg Med Chem Lett; 2011 Sep; 21(18):5259-61. PubMed ID: 21807509
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, biological activity, and SAR of antimycobacterial 9-aryl-, 9-arylsulfonyl-, and 9-benzyl-6-(2-furyl)purines.
Bakkestuen AK; Gundersen LL; Utenova BT
J Med Chem; 2005 Apr; 48(7):2710-23. PubMed ID: 15801862
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
[TBL] [Abstract][Full Text] [Related]
40. Identification, synthesis, and pharmacological evaluation of tetrahydroindazole based ligands as novel antituberculosis agents.
Guo S; Song Y; Huang Q; Yuan H; Wan B; Wang Y; He R; Beconi MG; Franzblau SG; Kozikowski AP
J Med Chem; 2010 Jan; 53(2):649-59. PubMed ID: 20000470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]